The Cardior acquisition may revolutionize the management and treatment of cardiovascular disease, ultimately benefiting both physicians and patients. The recent acquisition of Cardior Pharmaceuticals by Novo Nordisk marks a significant milestone in...
![PW-Circle-Logo-lockup_Horizontal](https://cdn.physiciansweekly.com/wp-content/uploads/2024/02/PW-Circle-Logo-lockup_Horizontal.webp)